Qualified Settlement Funds and Mass Tort Settlement Administration

How a QSF, a special master, and a points-based allocation grid actually move a global mass tort settlement from agreement to individual payment.

How does a mass tort settlement actually get distributed to thousands of individual plaintiffs? Almost always through a qualified settlement fund established under Internal Revenue Code § 468B and its implementing Treasury regulations, which allows a defendant to deposit the aggregate settlement amount into a court-supervised fund and receive an immediate tax deduction and release from further liability, while the fund itself takes time to allocate and distribute money to individual claimants under a court-approved plan.

A qualified settlement fund exists specifically to solve a timing problem: a defendant wants finality and a deduction now, while thousands of individual plaintiffs' claims cannot realistically be valued and paid simultaneously, at the moment of settlement, since determining each plaintiff's specific share requires reviewing individual medical records, exposure history, and other case-specific facts. The QSF holds the funds as a taxable entity in its own right while that allocation work proceeds, with a court retaining continuing jurisdiction over the fund's administration.

A special master or claims administrator is typically appointed to oversee the allocation process, applying a points-based grid the parties negotiate as part of the settlement — assigning point values to factors such as injury severity, duration of exposure or product use, age, and other case-specific criteria, then converting each claimant's point total into a dollar allocation from the fund's total pool. This grid-based approach allows a settlement to treat thousands of individually different claims consistently, without litigating each one separately, while still differentiating compensation based on relative injury severity.

Common benefit funds and holdback provisions are a related administrative feature specific to MDL and coordinated mass tort proceedings. Courts overseeing an MDL frequently order a percentage holdback from each individual settlement to fund the common benefit work — lead counsel's efforts on behalf of the entire plaintiff population, including establishing general causation and developing the bellwether trial record — that benefited all claimants, not just those whose individual cases were tried. This holdback is deducted before a claimant's individual allocation is finalized, alongside any medical liens and attorney fees.

Lien resolution is frequently the single biggest source of delay in actually getting funds to individual claimants after a settlement amount is agreed. Medicare Secondary Payer obligations, private health insurer subrogation claims, and hospital or provider liens must generally be identified and resolved, often through a dedicated lien resolution vendor working within the QSF process, before a claimant's net distribution can be finalized — which is why the gap between a headline settlement announcement and actual payment to plaintiffs can run well over a year even after the aggregate amount is agreed.

The QSF itself is a taxable entity, separately responsible for its own tax filings while it holds and administers settlement funds, which is a distinct compliance obligation from either the defendant's or the individual claimants' own tax returns. Trustees or administrators typically engage a qualified settlement fund tax specialist to handle these filings, since a QSF earning investment income on funds awaiting distribution, or holding funds across multiple tax years while allocation proceeds, generates its own tax reporting obligations independent of what any individual plaintiff eventually owes on their personal recovery.

For a firm or fund financing a mass tort inventory, understanding QSF and lien-resolution mechanics is directly relevant to structuring a facility's repayment expectations. A facility that assumes proceeds will flow to the firm immediately upon a headline settlement announcement will consistently be disappointed by the actual administrative timeline, since meaningful money typically does not move until the special master's allocation work and the lien resolution process are substantially complete. Facilities structured with this realistic administrative timeline in mind — rather than around the announced settlement date — tend to avoid the false signal of an apparent default or shortfall that is really just the ordinary, predictable lag of QSF administration playing out as expected.

Firms preparing to move a large inventory of claims through a QSF's allocation process typically build a centralized claims database well before the settlement is finalized, capturing each plaintiff's medical records, exposure history, and the specific facts the negotiated points grid will use to calculate that claimant's allocation. Firms that wait until the settlement is announced to begin assembling this documentation routinely find themselves at the back of the special master's processing queue relative to firms that arrive with organized, complete claims files, since the special master's office typically processes claims in the order they are submitted in substantially complete form rather than in the order the underlying cases were filed.

Coordination with the lien resolution vendor is a similarly practical, process-driven task rather than a legal one: firms typically route each claimant's Medicare, private insurer, and provider lien information to the vendor as early in the process as possible, since lien identification and negotiation can proceed in parallel with the special master's allocation work rather than only after an individual allocation amount is finalized. For a facility financing the firm's docket through this period, funders typically ask for periodic reporting on where the inventory sits in this pipeline — claims submitted, claims allocated, liens resolved, distributions made — since that pipeline position, not the headline settlement date, is what actually predicts when proceeds will reach the firm and, in turn, when the facility can expect repayment.

Sources: 26 U.S.C. § 468B and Treas. Reg. §§ 1.468B-1 through 1.468B-5 (qualified settlement funds); 42 U.S.C. § 1395y(b) (Medicare Secondary Payer Act, relevant to lien resolution within QSF administration).

Criterica Capital evaluates mass tort inventories with an understanding of how QSF administration, common benefit holdbacks, and lien resolution affect the timing and net amount of proceeds ultimately reaching plaintiffs and firms, incorporating that timeline into how portfolio facilities are structured and revalued. Firms managing mass tort inventories through settlement administration can contact our institutional team to discuss financing structured around these realistic timelines.

Discuss your matter with our institutional team.